Westfield Capital Management Portfolio holdings
AUM
$23.8B
This Quarter Return
+12.32%
1 Year Return
+35.69%
3 Year Return
+149.71%
5 Year Return
+223.91%
10 Year Return
+784.38%
AUM
$15.4B
AUM Growth
+$15.4B
(+6.2%)
Cap. Flow
-$36.9M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
263
New
33
Increased
66
Reduced
123
Closed
28
Top Buys
| 1 |
Darden Restaurants
DRI
|
$148M |
| 2 |
American Tower
AMT
|
$106M |
| 3 |
Netflix
NFLX
|
$90.3M |
| 4 |
Target
TGT
|
$83.8M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
$65.7M |
Top Sells
| 1 |
L3Harris
LHX
|
$136M |
| 2 |
ServiceNow
NOW
|
$122M |
| 3 |
Novartis
NVS
|
$74.9M |
| 4 |
Willis Towers Watson
WTW
|
$74.9M |
| 5 |
Hilton Worldwide
HLT
|
$71.9M |
Sector Composition
| 1 | Technology | 32.38% |
| 2 | Healthcare | 21.38% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 12.1% |
| 5 | Financials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
NXP Semiconductors
NXPI
$57.5B
| $49.1M | 0.32% |
393,692
-110,587
| -22% | -$13.8M |
|
|
AYX
102
DELISTED
Alteryx, Inc.
AYX
| $49.1M | 0.32% |
+432,279
| New | +$49.1M |
|
|
XYZ
103
Block, Inc.
XYZ
$46.2B
| $48.6M | 0.31% |
298,983
-138,231
| -32% | -$22.5M |
|
104
BioMarin Pharmaceuticals
BMRN
$11.3B
| $48.5M | 0.31% |
637,080
-27,977
| -4% | -$2.13M |
|
105
Sarepta Therapeutics
SRPT
$1.98B
| $48M | 0.31% |
342,155
+40,010
| +13% | +$5.62M |
|
106
NVIDIA
NVDA
$4.13T
| $47.7M | 0.31% |
88,065
-132,387
| -60% | -$71.7M |
|
107
Lumentum
LITE
$9.38B
| $47.5M | 0.31% |
631,953
+38,194
| +6% | +$2.87M |
|
108
Lam Research
LRCX
$123B
| $46.7M | 0.3% |
+140,693
| New | +$46.7M |
|
109
Celanese
CE
$4.87B
| $46.6M | 0.3% |
+433,871
| New | +$46.6M |
|
110
MongoDB
MDB
$25.2B
| $46.4M | 0.3% |
200,302
+41,752
| +26% | +$9.67M |
|
|
CTLT
111
DELISTED
CATALENT, INC.
CTLT
| $45.9M | 0.3% |
535,376
-510,185
| -49% | -$43.7M |
|
|
NUAN
112
DELISTED
Nuance Communications, Inc.
NUAN
| $45.4M | 0.29% |
1,368,696
-81,585
| -6% | -$2.71M |
|
113
Essential Properties Realty Trust
EPRT
$6.12B
| $44M | 0.28% |
2,401,820
+672,767
| +39% | +$12.3M |
|
114
FMC
FMC
$4.62B
| $43.4M | 0.28% |
409,369
-4,969
| -1% | -$526K |
|
115
Insmed
INSM
$30.4B
| $42.8M | 0.28% |
1,332,488
+295,777
| +29% | +$9.51M |
|
116
Burlington
BURL
$18.4B
| $42.1M | 0.27% |
204,085
-33,039
| -14% | -$6.81M |
|
|
RP
117
DELISTED
RealPage, Inc.
RP
| $41.9M | 0.27% |
726,553
-10,039
| -1% | -$579K |
|
|
AMED
118
DELISTED
Amedisys
AMED
| $41.5M | 0.27% |
175,519
-133,209
| -43% | -$31.5M |
|
|
PLAN
119
DELISTED
Anaplan, Inc.
PLAN
| $41.4M | 0.27% |
662,075
-9,579
| -1% | -$599K |
|
120
Viavi Solutions
VIAV
$2.57B
| $40.6M | 0.26% |
3,463,778
+81,571
| +2% | +$957K |
|
|
PFPT
121
DELISTED
Proofpoint, Inc.
PFPT
| $40.3M | 0.26% |
381,391
+23,245
| +6% | +$2.45M |
|
122
Churchill Downs
CHDN
$7.11B
| $39.5M | 0.26% |
241,418
+109,774
| +83% | +$18M |
|
123
lululemon athletica
LULU
$23.8B
| $39.5M | 0.26% |
119,997
-38,533
| -24% | -$12.7M |
|
124
National Vision
EYE
$1.79B
| $39.2M | 0.25% |
+1,025,075
| New | +$39.2M |
|
125
Neurocrine Biosciences
NBIX
$13.5B
| $38.9M | 0.25% |
404,251
+4,785
| +1% | +$460K |
|